Legend Biotech (LEGN) Leases: 2019-2025
Historic Leases for Legend Biotech (LEGN) over the last 5 years, with Sep 2025 value amounting to $142.3 million.
- Legend Biotech's Leases rose 43.12% to $142.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $142.3 million, marking a year-over-year increase of 43.12%. This contributed to the annual value of $101.9 million for FY2024, which is 26.62% up from last year.
- Per Legend Biotech's latest filing, its Leases stood at $142.3 million for Q3 2025, which was up 11.89% from $127.2 million recorded in Q2 2025.
- Legend Biotech's 5-year Leases high stood at $142.3 million for Q3 2025, and its period low was $7,547 during Q1 2021.
- Moreover, its 3-year median value for Leases was $99.5 million (2024), whereas its average is $98.8 million.
- As far as peak fluctuations go, Legend Biotech's Leases skyrocketed by 526,877.61% in 2022, and later fell by 0.35% in 2024.
- Over the past 5 years, Legend Biotech's Leases (Quarterly) stood at $38.3 million in 2021, then spiked by 45.21% to $55.6 million in 2022, then spiked by 44.81% to $80.5 million in 2023, then increased by 26.62% to $101.9 million in 2024, then surged by 43.12% to $142.3 million in 2025.
- Its Leases was $142.3 million in Q3 2025, compared to $127.2 million in Q2 2025 and $107.2 million in Q1 2025.